搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ureaplasma parvum serovar 3 Probable transcriptional regulatory protein UU295 (UU295) CSB-YP889446UAO
CSB-EP889446UAO
CSB-BP889446UAO
CSB-MP889446UAO
CSB-EP889446UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Arginine--tRNA ligase (argS), partial CSB-YP889447UAO
CSB-EP889447UAO
CSB-BP889447UAO
CSB-MP889447UAO
CSB-EP889447UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 UPF0154 protein UU265 (UU265), partial CSB-YP889448UAO1
CSB-EP889448UAO1
CSB-BP889448UAO1
CSB-MP889448UAO1
CSB-EP889448UAO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L18 (rplR) CSB-YP889449UAO
CSB-EP889449UAO
CSB-BP889449UAO
CSB-MP889449UAO
CSB-EP889449UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 30S ribosomal protein S17 (rpsQ) CSB-YP889450UAO
CSB-EP889450UAO
CSB-BP889450UAO
CSB-MP889450UAO
CSB-EP889450UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L4 (rplD) CSB-YP889451UAO
CSB-EP889451UAO
CSB-BP889451UAO
CSB-MP889451UAO
CSB-EP889451UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP889452UAO
CSB-EP889452UAO
CSB-BP889452UAO
CSB-MP889452UAO
CSB-EP889452UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Phosphate import ATP-binding protein PstB (pstB) CSB-YP889453UAO
CSB-EP889453UAO
CSB-BP889453UAO
CSB-MP889453UAO
CSB-EP889453UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Enolase (eno) CSB-YP889454UAO
CSB-EP889454UAO
CSB-BP889454UAO
CSB-MP889454UAO
CSB-EP889454UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Triosephosphate isomerase (tpiA) CSB-YP889455UAO
CSB-EP889455UAO
CSB-BP889455UAO
CSB-MP889455UAO
CSB-EP889455UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Tryptophan--tRNA ligase (trpS) CSB-YP889456UAO
CSB-EP889456UAO
CSB-BP889456UAO
CSB-MP889456UAO
CSB-EP889456UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU165.2 (UU165.2), partial CSB-YP889457UAO1
CSB-EP889457UAO1
CSB-BP889457UAO1
CSB-MP889457UAO1
CSB-EP889457UAO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU156 (UU156) CSB-YP889458UAO
CSB-EP889458UAO
CSB-BP889458UAO
CSB-MP889458UAO
CSB-EP889458UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU148 (UU148) CSB-YP889459UAO
CSB-EP889459UAO
CSB-BP889459UAO
CSB-MP889459UAO
CSB-EP889459UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 ATP synthase subunit alpha (atpA), partial CSB-YP889460UAO
CSB-EP889460UAO
CSB-BP889460UAO
CSB-MP889460UAO
CSB-EP889460UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 DNA ligase (ligA), partial CSB-YP889461UAO
CSB-EP889461UAO
CSB-BP889461UAO
CSB-MP889461UAO
CSB-EP889461UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU111 (UU111) CSB-YP889462UAO
CSB-EP889462UAO
CSB-BP889462UAO
CSB-MP889462UAO
CSB-EP889462UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU089.1 (UU089.1) CSB-YP889463UAO
CSB-EP889463UAO
CSB-BP889463UAO
CSB-MP889463UAO
CSB-EP889463UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 HPr kinase/phosphorylase (hprK) CSB-YP889464UAO
CSB-EP889464UAO
CSB-BP889464UAO
CSB-MP889464UAO
CSB-EP889464UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Ribonuclease R (rnr), partial CSB-YP889465UAO
CSB-EP889465UAO
CSB-BP889465UAO
CSB-MP889465UAO
CSB-EP889465UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>